DalsnaFinance › Analyst accuracy › TD Cowen › ABT target
TD Cowen raises Abbott Labs stock price target on cancer diagnostics growth
TD Cowen raised its price target on Abbott Laboratories stock (NYSE:ABT) to $135 from $115 while maintaining a Buy rating.
A fact about what TD Cowen published, as reported by Investing.com India, not a recommendation from Dalsna Finance; TD Cowen is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.